ANI Pharmaceuticals, Inc. (ANIP) Ownership

$89.64

north_east
$0.51 (0.57%)
Day's range
$89.56
Day's range
$92.52

ANI Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 2.55 M $233.48 M   -1.23% 12.85%
VANGUARD GROUP INC 11/07/2025 1.28 M $117.02 M   0.01% 6.44%
STATE STREET CORP 11/14/2025 711.71 K $65.19 M   -0.62% 3.59%
GLOBAL ALPHA CAPITAL MANAGEMENT LTD. 11/13/2025 630.59 K $57.76 M   -26.85% 3.18%
UBS GROUP AG 11/13/2025 589.87 K $54.03 M   45.76% 2.97%
CITADEL ADVISORS LLC 11/14/2025 580.09 K $53.14 M   1.84% 2.92%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 505.43 K $46.30 M   -8.75% 2.55%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 458.01 K $41.96 M   7.13% 2.31%
DEEP TRACK CAPITAL, LP 11/14/2025 450.00 K $41.22 M   -35.71% 2.27%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 399.09 K $36.56 M   100.00% 2.01%
NUVEEN, LLC 11/12/2025 395.08 K $36.19 M   6.50% 1.99%
GOLDMAN SACHS GROUP INC 11/14/2025 379.03 K $34.72 M   84.33% 1.91%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 360.18 K $32.99 M   100.00% 1.82%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 11/12/2025 348.68 K $31.94 M   -28.92% 1.76%
RUBRIC CAPITAL MANAGEMENT LP 11/14/2025 343.41 K $31.46 M   33.28% 1.73%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 340.24 K $31.17 M   570.52% 1.72%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 317.50 K $29.08 M   0.00% 1.60%
AMERIPRISE FINANCIAL INC 11/14/2025 291.84 K $26.73 M   -23.72% 1.47%
MACQUARIE GROUP LTD 11/13/2025 291.13 K $26.67 M   -31.29% 1.47%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 286.15 K $26.21 M   2,785.73% 1.44%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 272.90 K $25.00 M   112.56% 1.38%
RANGER INVESTMENT MANAGEMENT, L.P. 11/05/2025 271.35 K $24.86 M   -49.21% 1.37%
ABRDN PLC 11/07/2025 269.68 K $24.70 M   -26.30% 1.36%
DEUTSCHE BANK AG\ 11/13/2025 252.57 K $23.14 M   13.93% 1.27%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 235.66 K $21.59 M   -8.53% 1.19%
DIVISADERO STREET CAPITAL MANAGEMENT, LP 11/14/2025 234.22 K $21.45 M   100.00% 1.18%
MORGAN STANLEY 11/14/2025 232.03 K $21.25 M   15.51% 1.17%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 227.55 K $20.84 M   498.76% 1.15%
WALLEYE CAPITAL LLC 11/14/2025 216.31 K $19.81 M   531.24% 1.09%
D. E. SHAW & CO., INC. 11/14/2025 213.01 K $19.51 M   211.90% 1.07%
ROYAL BANK OF CANADA 11/14/2025 210.70 K $19.30 M   -0.65% 1.06%
NOMURA HOLDINGS INC 11/14/2025 195.52 K $17.91 M   347.28% 0.99%
BANK OF MONTREAL /CAN/ 11/13/2025 194.25 K $17.79 M   -8.47% 0.98%
KENNEDY CAPITAL MANAGEMENT LLC 11/13/2025 190.39 K $17.44 M   -28.70% 0.96%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 190.20 K $17.42 M   149.66% 0.96%
NORTHERN TRUST CORP 11/14/2025 188.60 K $17.28 M   -0.46% 0.95%
MIZUHO MARKETS AMERICAS LLC 10/29/2025 180.58 K $16.54 M   -15.15% 0.91%
LOOMIS SAYLES & CO L P 11/13/2025 172.14 K $15.77 M   -16.59% 0.87%
APIS CAPITAL ADVISORS, LLC 11/14/2025 164.00 K $15.02 M   28.13% 0.83%
TEACHER RETIREMENT SYSTEM OF TEXAS 10/30/2025 152.89 K $14.00 M   3.74% 0.77%
INVESCO LTD. 11/13/2025 150.66 K $13.80 M   -12.64% 0.76%
OBERWEIS ASSET MANAGEMENT INC/ 11/17/2025 138.90 K $12.72 M   0.00% 0.70%
JANE STREET GROUP, LLC 11/14/2025 134.44 K $12.31 M   100.00% 0.68%
BANK OF AMERICA CORP /DE/ 11/14/2025 130.73 K $11.98 M   -29.51% 0.66%
JPMORGAN CHASE & CO 11/26/2025 129.10 K $11.83 M   -50.90% 0.65%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 128.69 K $11.79 M   84.86% 0.65%
BANK OF NEW YORK MELLON CORP 11/03/2025 116.27 K $10.65 M   -2.12% 0.59%
CITIGROUP INC 11/10/2025 103.98 K $9.52 M   431.62% 0.52%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 98.49 K $9.02 M   -34.69% 0.50%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 94.10 K $8.62 M   -43.63% 0.47%

ANI Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 357 institutional investors and hedge funds held shares of ANI Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 2.55 M

VANGUARD GROUP INC: 1.28 M

STATE STREET CORP: 711,708

Global Alpha Capital Management Ltd.: 630,590

UBS Group AG: 589,874

CITADEL ADVISORS LLC: 580,085

102.88% of ANI Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 25.29 M shares in the last 24 months. This purchase volume represents approximately $2.27 B in transactions.